FEI Tribunal issues Final Decisions in human anti-doping case

The FEI Tribunal has issued its Final Decision in a human anti-doping case.

This case involves an adverse analytical finding for Hydrochlorothiazide and its metabolite, Chloraminophenamide, which are included in the category of class “S5 - Diuretics and Masking Agents” according to the World Anti-Doping Agency (WADA) Prohibited List.

A sample taken from the Argentinian athlete Fabian Sejanes (FEI ID 10001261) on 11 August 2022, during the FEI World Championships held in Herning, Denmark, from 5-14 August 2022, returned positive for the Prohibited Substance mentioned above. The athlete was notified of the violation of the FEI’s Anti-Doping Rules for Human Athletes (ADRHA) on 11 October 2022.

In its Final Decision, the FEI Tribunal decided to suspend the athlete for a period of 18-months, starting from the date of the FEI Tribunal Final Decision (27 October 2023). Additionally, the athlete was disqualified from all results obtained at the event as well as all other competitive results obtained by the athlete from the date of his sample collection were disqualified. Finally, the athlete was fined CHF 3,000 and asked to pay costs of CHF 1,500.

The parties can appeal to the Court of Arbitration for Sport (CAS) within 21 days of receipt of the decision.

The full text of the FEI Tribunal’s Final Decision is available here.

Article courtesy of the FEI